Duration of Phase A. The joint research and development activities in Phase A are scheduled for an initial term of four (4) years starting on the Effective Date. The Parties shall discuss in good faith an extension of Phase A at the latest three (3) months before the end of the initial term, provided that any extension of Phase A shall require the written mutual agreement between the Parties.β 3. Save as set forth in this Amendment No 3, all other terms and conditions of the Agreement shall remain in full force and effect. 4. This Amendment No 3 may be signed in any number of counterparts with the same effect as if the signatures to each counterpart were upon a single instrument, and all such counterparts together shall be deemed an original of the Amendment No 3.
Appears in 2 contracts
Sources: License and Collaboration Agreement (BioNTech SE), License and Collaboration Agreement (BioNTech SE)